Browse Studies — Arctuva

Phase 2

Bempedoic Acid Therapy for Polycystic Kidney Disease (BEAT-PKD) Randomized Clinical Trial

Autosomal dominant polycystic kidney disease (ADPKD), the most commonly inherited kidney disease, is characterized by the development of cysts in the kidney th…

ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Estimated

~$10 – $7,500

Kenneth HallowsNCT07282821

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several decades, ADPKD was regarded as an adult-ons…

ADPKD

Estimated

~$10 – $750

Children's Hospital of PhiladelphiaNCT04338048

Observational

Di-PKD: A Pilot Trial of a 12-Month Targeted Dietary Intervention on Cyst Progression in Patients With Autosomal Dominant Polycystic Kidney Disease

The goal of this interventional study is to evaluate the impact of a specific diet (low salt, limited caffeine, high potassium, low phosphate, limited protein,…

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Estimated

~$10 – $6,250

Loma Linda UniversityNCT06786260

Observational

Short-Term Metabolic Impacts of Ren-Nu: A Dietary Program for Individuals With Polycystic Kidney Disease

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant po…

Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Estimated

~$10 – $7,500

Richard FaticaNCT07454174